Literature DB >> 15865595

Life-threatening allergic bronchopulmonary aspergillosis in a well child with cystic fibrosis.

Emma Skowronski1, Dominic A Fitzgerald.   

Abstract

Allergic bronchopulmonary aspergillosis (ABPA) is an uncommon condition which may complicate asthma and cystic fibrosis; it is seldom considered life-threatening. We report a well 8-year-old boy with cystic fibrosis and normal lung function who progressed to respiratory failure over several days, attributable to ABPA. He recovered with non-invasive ventilation and oral corticosteroid and antifungal medications, regaining normal lung function within 2 months. To our knowledge, such an acute severe presentation of ABPA in a previously well child has not been reported before.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15865595     DOI: 10.5694/j.1326-5377.2005.tb06792.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  3 in total

1.  Life-threatening allergic bronchopulomnary aspergillosis treated with methylprednisolone and anti-IgE monoclonal antibody.

Authors:  Matthew F Thomas
Journal:  J R Soc Med       Date:  2009-07       Impact factor: 5.344

Review 2.  Asthma and Fungus: Role in Allergic Bronchopulmonary Aspergillosis (ABPA) and Other Conditions.

Authors:  Meenu Singh; Nandini Paul; Shreya Singh; Gyan Ranjan Nayak
Journal:  Indian J Pediatr       Date:  2018-03-17       Impact factor: 1.967

Review 3.  Childhood allergic bronchopulmonary aspergillosis.

Authors:  Kana Ram Jat; Pankaj C Vaidya; Joseph L Mathew; Sunil Jondhale; Meenu Singh
Journal:  Lung India       Date:  2018 Nov-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.